Cycc seeking alpha

Author: rqgv

August undefined, 2024

WebMay 27, 2013 · The company recently reported its Q1 2013 results on May 13, 2013. The ensuing earnings call transcript can be found here at Seeking Alpha. The following points are some highlights from that call ... WebMar 27, 2014 · CYCC has pivotal catalysts over the next year and a half. Company trades at a market cap of ~$70M vs. peers who command valuations upwards of 6x CYCC's MC. …

Cyclacel Pharmaceuticals Q2 2024 Earnings Preview - SeekingAlpha

WebApr 12, 2024 · Shares of biopharmaceutical company Cyclacel Pharmaceuticals (CYCC) have added 13.2% in premarket trading on Tuesday after announcing publication of preclinical data confirming that... WebNov 8, 2024 · Cyclacel Pharmaceuticals (CYCC) is scheduled to announce Q3 earnings results on Wednesday, November 9th, after market close.The consensus EPS Estimate … deep cleaning service description

Cyclacel Heats Up On Clinical Trial Progression - SeekingAlpha

WebFeb 21, 2013 · Seeking Alpha Contributor Steve Rosenman remarks from his December 2012 article; As for AML, Cyclacel began the SEAMLESS pivotal Phase III trial for the company's sapacitabine oral capsules as a ... WebNov 9, 2024 · Cyclacel Pharmaceuticals press release ( NASDAQ: CYCC ): Q3 GAAP EPS of -$0.42 beats by $0.14. Net loss for the three months ended September 30, 2024, was $5.1 million, compared to $5.0 million... WebAug 7, 2024 · Cyclacel Pharmaceuticals is an oncology company with two major value drivers in Phase 1/2 trials and overdue catalysts. It trades at an $11 million market cap, … federal university of amazonas

Cyclacel Pharmaceuticals GAAP EPS of -$0.42 beats by $0.27 - SeekingAlpha

Cyclacel Explained: Answers About The Long Misunderstood And ...

WebSep 7, 2013 · Cyclacel stock is presently trapped in a three month range of 25 cents or 8% of the current share price after having fallen from a high of $8.18 on December 5, 2012 to today's price of $3.07 (up... WebApr 20, 2024 · Cyclacel Pharmaceuticals (NASDAQ:CYCC) has entered into an agreement with the University of Edinburgh to study fadraciclib (CYC065) and seliciclib (CYC202 or R-roscovitine), its clinical-stage ... deep cleaning services ajmanWebFeb 25, 2024 · Cyclacel Pharmaceuticals (NASDAQ: CYCC): Q4 GAAP EPS of -$2.74 misses by $2.21. As of December 31, 2024, cash and cash equivalents totaled $33.4 million. Additional proceeds of $4.3 million were... federal university of bauchi

"WebFeb 14, 2013 · On June 18, 2010, Cyclacel filed a countersuit, charging Celgene with infringement of each of the four Cyclacel-owned Skov Patents and seeking damages for Celgene's infringement as well as ... " - Cycc seeking alpha

Cycc seeking alpha

WebAug 22, 2016 · Cyclacel’s (NASDAQ:CYCC) long-suffering shareholders will shortly see the outcome of its seemingly endless, so-called Seamless trial of sapacitabine in elderly patients with newly diagnosed ... WebMar 29, 2024 · Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2024 Results - Earnings Call Transcript Seeking Alpha Sale! Get 50% off Premium: Discover this season's earnings surprises »...

Did you know?

WebSep 20, 2010 · CYCC is a prime takeover target with its pipeline, zero debt, and $19M cash on hand. I’d expect a minimum offer of $150M, which would be roughly $4.20 per share. … WebDec 30, 2024 · Cyclacel Pharmaceuticals, Inc. (CYCC) dividend summary: yield, payout, growth, announce date, ex-dividend date, payout date and Seeking Alpha Premium …

WebJan 24, 2013 · The company's current market capitalization is a paltry $50 million with $20 million in cash. Based on sum-of-parts analysis (see tables below), we believe Cyclacel is at least worth a market cap... WebOct 26, 2024 · Cyclacel dips (CYCC-10.3%) on average volume as investors appear underwhelmed with data from a Phase 1 study evaluating fadraciclib for solid tumors.Data were presented at the EORTC-NCI-AACR ...

WebMay 11, 2024 · Cyclacel Pharmaceuticals press release (CYCC): Q1 GAAP EPS of -$0.42 beats by $0.27.As of March 31, 2024, cash and cash equivalents totaled $29.6 million, compared to $36.6 million as... WebMar 6, 2024 · Cyclacel Pharmaceuticals press release ( NASDAQ: CYCC ): Q4 GAAP EPS of -$0.60 misses by $0.12. Report final data from dose escalation stage and RP2D determination from the 065-101 study of oral...

WebMar 29, 2024 · Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2024 Results Conference Call March 28, 2024 4:30 PM ET. Company Participants. Spiro Rombotis - …

WebFeb 28, 2024 · Get the latest news and real-time alerts from Cyclacel Pharmaceuticals, Inc. (CYCC) stock at Seeking Alpha. federal university of cearaWebJun 13, 2024 · Brookline Capital markets initiated coverage on CYCC with $22/share price target on 5/9. Two other analysts have an average BUY rating on the stock with an … federal university of gombeWebOct 16, 2012 · Cyclacel Heats Up On Clinical Trial Progression Oct. 16, 2012 5:17 PM ET Cyclacel Pharmaceuticals, Inc. (CYCC) Bio Insights 1.73K Follower s Follow The market is beginning to bid for shares of... federal university of education in nigeriaWebMar 20, 2012 · Seeking Alpha - Go to Homepage. Trending. My Portfolio. My Analysts ... Cyclacel: An Intriguing Long Shot. Mar. 20, 2012 8:58 AM ET Cyclacel Pharmaceuticals, Inc. (CYCC) ASTX, ONXX, JNJ, SNY 7 ... deep cleaning services capitolaWebApr 1, 2024 · Cyclacel will present additional CYC065 Phase 1 data on solid tumors at the 2024 AACR Annual Meeting on April 15, 2024. Following the March 28, 2024 4Q FY 2024 ER, Andrew Fein from H.C. deep cleaning services brickell federal university of birnin kebbiWebApr 6, 2024 · A Seeking Alpha follower recently inquired on what I thought about Cyclacel Pharmaceuticals (NASDAQ:CYCC). I had no answer as I have never even glanced at … federal university of cear谩